NOS1 and central nervous system cancer: The SW1088 glioma line showed no ROS induction despite incubation with 2-ME; however, it induced RNS across the entire concentration range of the compound at both physiologically and pharmacologically relevant concentrations, and in addition, it upregulated nNOS expression.